News and Publications

News & publications

Related news & insights - Will Axtell

Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures
Posted: 12/07/2022
The corporate team at Penningtons Manches Cooper has advised shareholders of Titian Software, a leading sample management software solution provider to the life sciences sector, on the significant, majority investment from Battery Ventures, a US technology-focused investment firm. Titian will use the new funds to support organic growth as well as potential future acquisitions......>>
Penningtons Manches Cooper advises US company Echo Healthcare on its cross-border acquisition of Immersive Interactive
Posted: 17/06/2022
The corporate team at Penningtons Manches Cooper has advised Echo Healthcare Inc, a US medtech company, on its strategic cross-border acquisition of Immersive Interactive......>>
Penningtons Manches Cooper advises bioanalysis and toxicology laboratory Analytical Services International on acquisition by Forensic Access
Posted: 23/03/2022
The corporate team at Penningtons Manches Cooper has advised the shareholders of Analytical Services International (ASI) on the sale of the company to private equity backed Forensic Access. ASI, headquartered in London, is a leading laboratory providing services including clinical trial bioanalysis, forensic toxicology and therapeutic drug monitoring......>>
Penningtons Manches Cooper advises next generation virus diagnostic company OxDX on its spin-out from Oxford University
Posted: 18/02/2022
The corporate team at Penningtons Manches Cooper has advised OxDX on the completion of its spin-out from Oxford University and its £2.6 million pre-seed funding. The funding will be used to develop its AI-powered diagnostic technology, which will be used to improve the speed, cost and accuracy of diagnostics worldwide......>>
Corporate team advises on major cross-border life sciences transaction
Posted: 27/10/2021
The Penningtons Manches Cooper corporate team has advised the shareholders of ATDBio on its sale to NASDAQ Stockholm listed Biotage AB. The purchase price was approximately £45m on a debt free and cash free basis......>>
Penningtons Manches Cooper advises on cross-border sale of ITSM software developer
Posted: 25/08/2021
Penningtons Manches Cooper has advised on the sale of Snapbytes to Appfire, a leading US provider of software development apps. With more than 4,300 global installations of its IT Service Management (ITSM) applications, Snapbytes is the maker of the most-downloaded service-level agreement app on the Atlassian Marketplace - one of the largest enterprise software marketplaces......>>
Penningtons Manches Cooper advises biomaterials company on £4.5 million fundraising round
Posted: 17/05/2021
The corporate team at Penningtons Manches Cooper has acted for The Electrospinning Company (Electrospinning) on the completion of a £4.5 million fundraising round, its largest to date......>>
Penningtons Manches Cooper advises Oxford University spin-out aiming to develop cancer vaccines
Posted: 23/04/2021
The corporate and IP team at Penningtons Manches Cooper has advised new immuno-oncology company, OxVax, on its spin-out from Oxford University......>>
Future Fund opens for applications and final details are circulated
Posted: 20/05/2020
At the end of April, the Chancellor announced a new bailout programme aimed at venture capital-backed businesses that were struggling to survive the pandemic, but were not otherwise eligible for the existing coronavirus schemes. The package included a £250- million convertible loan scheme for high-growth companies, called “Future Fund”...…>>
Bounce back loans to provide a boost for small businesses
Posted: 28/04/2020
Under the scheme businesses will be able to borrow between £2,000 and £50,000. The Chancellor’s recent tweets suggest the borrowing amount will be 25% of turnover up to a maximum of £50,000 albeit the available guidance online does not reflect this yet......>>

«
1
2
»

Filter news & insights

Filter by keyword: Filter by expertise:

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Value

Contact an office

London (Head office)
+44 (0)20 7457 3000
London (Minories)
+44 (0)20 7481 8851
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2022 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority.